The regulation of growth hormone secretion

Frontiers of Hormone Research

Volumn 24, Issue , 1999, Pages 152-175

  Ghigo, E ^a   Arvat, E ^a   Gianotti, L ^a   Maccario, M ^a   Camanni, F ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 54249159359     PISSN: 03013073     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000061007     Document Type: Article

References (103)

1. Bauman G: Growth hormone heterogeneity genes, isohormones, variants, and binding proteins. Endocr Rev 1991;12:424-449.
2. Strobl JS, Thomas MJ: Human growth hormone. Pharmacol Rev 1994;46:1-34.
3. Parks JS, Abdul-Latif H, Kinoshita E, Meacham LR, Pfaffle RW, Brown MR: Genetics of growth hormone gene expression. Horm Res 1993;40:54-61.
4. Vila V, Jimenez O, Guell A, Castrillo JL: Pit-1 and Pit-2 role in growth hormone gene regulation. J Pediatr Endocrinol 1993;6:225-228.
5. Theill LE, Karin M: Transcriptional control of GH expression and anterior pituitary development. Endocr Rev 1993;14:670-689.
6. Veldhuis JD: New modalities for understanding dynamic regulation of the somatotropic (GH) axis: Explication of gender differences in GH neuroregulation in the human. J Pediatr Endocrinol Metab 1996;9:237-253.
7. Iranmanesh A, Veldhuis JD: Clinical pathophysiology of the somatotropic (GH) axis in adults; in Veldhuis JD (ed): Neuroendocrinology. I. Endocrinol Metab Clin North Am. Philadelphia, Saunders, 1992, vol 21, pp 783-817.
8. Bauman G, Shaw MA, Amburn K: Circulating growth hormone binding proteins. J Endocrinol Invest 1994;17:67-81.
9. Postel-Vinay MC: Regulation of the growth hormone-binding proteins in human plasma. Acta Endocrinol 1991;124:10-13.
10. Kelly PA, Ali S, Rozakis M, Goujon L, Nagano M, Pellegrini I, Gould D, Djiane J, Edery M, Finidori J: The growth hormone/prolactin receptor family. Recent Prog Horm Res 1993;48:123-164.
11. Herington AC: Growth hormone receptor and binding protein: Distribution and function. J Pediatr Endocrinol 1993;6:235-240.
12. Jones J, Clemmons DR: Insulin-like growth factors and their binding proteins: Biological actions. Endocr Rev 1995;16:3-34.
13. Zapf J: Physiological role of the insulin-like growth factor binding proteins. Eur J Endocrinol 1995;132:645-654.
14. Furlanetto RW: Insulin-like growth factor measurements in the evaluation of growth hormone secretion. Horm Res 1990;33(suppl 4):25-30.
15. de Boer H, Block GJ, van der Veen EA: Clinical aspects of growth hormone deficiency in adults. Endocr Rev 1995;16:63-86.
16. Thissen JP, Ketesleger JM, Underwood LE: Nutritional regulation of insulin-like-growth-factors. Endocr Rev 1994;15:80-85.
17. Ross RJM, Chew SL: Acquired growth hormone resistance. Eur J Endocrinol 1995;132:655-660.
18. Davidson MB: Effect of growth hormone on carbohydrate and lipid metabolism. Endocr Rev 1987;8:115-131.
19. Casanueva FF: Physiology of growth hormone secretion and action; in Melmed S (ed): Endocrinol Metab Clin North Am. Philadelphia, Saunders, 1992, vol 21, pp 483-492.
20. De Feo PP: Hormonal regulation of human protein metabolism. Eur J Endocrinol 1996;135:7-18.
21. Johansson AG, Lindh E, Ljunghall S: Growth hormone, insulin-like growth factor I, and bone: A clinical review. J Intern Med 1993;234:553-560.
22. Eriksen EF, Kassem M, Langdahl B: Growth hormone, insulin-like growth factors and bone remodelling. Eur J Clin Invest 1996;26:525-534.
23. Holmes SJ, Shalet SM: Role of growth hormone and sex steroids in achieving and maintaining normal bone mass. Horm Res 1996;45:86-93.
24. Isaksson OGP, Lindhal A, Nilsson AL: Mechanisms of the stimulatory effect of growth hormone on longitudinal bone growth. Endocr Rev 1987;8:426-438.
25. Wabitsch M, Hauner H, Heinze E, Teller W: In vitro effects of growth hormone in adipose tissue. Acta Pediatr 1994;406:48-53.
26. Angelin B, Rudling M: Growth hormone and hepatic lipoprotein metabolism. Curr Opin Lipidol 1994;5:160-165.
27. Florini JR, Ewton DZ, Coolican SA: Growth hormone and the insulin-like growth factor system in myogenesis. Endocr Rev 1996;17:481-517.
28. Wolf SE, Barrow RE, Herndon DN: Growth hormone and IGF-I therapy in the hypercatabolic patient; in Ross RJM, Savage MO (eds): Growth Hormone Resistance. Clin Endocrinol Metab. London, Baillière Tindall, 1996, vol 10, pp 447-458.
29. Juul A, Jorgensen JO, Christiansen JS, Muller J, Skakkeboek NE: Metabolic effects of GH: A rationale for continued GH treatment of GH-deficient adults after cessation of linear growth. Horm Res 1995;44:64-72.
30. Moller N, Jorgensen JO, Moller J, Orskov L, Ovesen P, Schmitz O, Christiansen JS, Orskov H: Metabolic effects of growth hormone in humans. Metabolism 1995;44:33-36.
31. Marcus C, Margery V, Kamel A, BronnegardM: Effects of growth hormone on lipolysis in humans. Acta Pediatr 1994;406:54-59.
32. Thorner MO, Hartman ML, Vance ML, Pezzoli S, Ampleford EJ: Neuroendocrine regulation of growth hormone secretion. Neurosci Biobehav Rev 1995;19:465-468.
33. Dieguez C, Page MD, Scanlon MF: Growth regulation and its alteration in disease states. Clin Endocrinol 1988;28:109-143.
34. Cuneo RC, Wallace JD: Growth hormone, insulin-like growth factors and sport. Endocrinol Metab 1994;1:3-13.
35. Corpas E, Harman SM, Blackman S: Human growth hormone and human aging. Endocr Rev 1993;14:20-39.
36. Ghigo E, Arvat E, Gianotti L, Ramunni J, Di Vito L, Maccagno B, Grottoli S, Camanni F: Human aging and the GH/IGF-I axis. J Pediatr Endocrinol Metab 1996;9:271-278.
37. Takahashi Y, Kipnis DM, Daughday WH: Growth hormone secretion during sleep. J Clin Invest 1968;47:2079-2090.
38. Koella WP: The organization and regulation of sleep. A review of the experimental evidence and a novel integrated model of organizing and regulating apparatus. Experientia 1984;40:309-338.
39. Ghigo E: Neurotransmitter control of growth hormone secretion; in De la Cruz (ed): Regulation of Growth Hormone and Somatic Growth. Amsterdam, Elsevier Science, 1992, pp 103-136.
40. Jenkins RC, Ross RJM: Acquired growth hormone resistance in catabolic states; in Ross RJM, Savage MO (eds): Growth Hormone Resistance. Clin Endocrinol Metab. London, Baillière Tindall, 1996, vol 10, pp 411-419.
41. Hartman ML: Physiological regulators of growth hormone secretion; in Juul A, Jorgensen JOL (eds): Growth Hormone in Adults. Cambridge, Cambridge University Press, 1996, pp 5-35.
42. Jenkins RC, Ross RJM: The endocrinology of the critically ill. Curr Opin Endocrinol Diabetes 1996;3:138-145.
43. Bentham J, Rodriguez-Arnao J, Ross RJM: Acquired growth hormone resistance in patients with hypercatabolism. Horm Res 1993;40:87-91.
44. Van den Berghe G, de Zegher F: Anterior pituitary function during critical illness and dopamine treatment. Crit Care Med 1996;24:1580-1590.
45. Donaghy AJ, Baxter RC: Insulin-like growth factor bioactivity and its modification in growth hormone-resistant states; in Ross RJM, Savage MO (eds): Growth Hormone Resistance. Clin Endocrinol Metab. London, Baillière Tindall, 1996, vol 10, pp 421-447.
46. Scanlon MF, Issa BG, Dieguez C: Regulation of growth hormone secretion. Neuroendocrinology 1996;46:149-154.
47. Muller EE, Cocchi D, Ghigo E, Arvat E, Locatelli V, Camanni F: Growth hormone response to GHRH during lifespan. J Pediatr Endocrinol 1993;6:5-13.
48. Keljiman M: Age-related alterations of the growth hormone/insulin-like-growth-factor I axis. JAGS Geriatr Biosci 1991;39:295-307.
49. Hoffman AR, Pyka G, Lieberman SA, Ceda GP, Marcus R: The somatopause; in Muller EE, Cocchi D, Locatelli V (eds): Growth Hormone and Somatomedins during Lifespan. Berlin, Springer, 1993, pp 265-274.
50. Chatelain P, Claris O, Lapillone A, Dimayo M, Salle B: Fetal and neonatal somatotrope function. Front Paediatr Neuroendocrinol 1994;20:127-130.
51. Ho KK, Weissberger AJ: Secretory patterns of growth hormone according to sex and age. Horm Res 1990;33:7-11.
52. Kerrigan JR, Rogol AD: The impact of gonadal steroid hormone action on growth hormone secretion during childhood and adolescence. Endocr Rev 1992;13:281-298.
53. Wehrenberg WB, Giustina A: Mechanisms and pathways of gonadal steroid modulation of growth hormone secretion. Endocr Rev 1992;13:299-308.
54. Veldhuis JD: New modalities for understanding dynamic regulation of the somatotropic (GH) axis: Explication of gender differences in GH neuroregulation in the human. J Pediatr Endocrinol Metab 1996;9:237-253.
55. Muller EE, Rolla M, Ghigo E, Belliti D, Arvat E, Andreoni A, Torsello A, Locatelli V, Camanni F: Involvement of brain catecholamines and acetylcholine in growth hormone hypersecretory states. Pathophysiological, diagnostic and therapeutic implications. Drugs 1995;50:805-837.
56. Shetty KR, Duthie EHJ: Anterior pituitary function and growth hormone use in the elderly; in Melmed S (ed): Endocrinol Metab Clin North Am. Philadelphia, Saunders, 1995, vol 24, pp 213-231.
57. Rudman D, Rao UMP: The hypothalamic-growth hormone-somatomedin C: The effect of aging; in Morley JE, Korenman SG (eds): Endocrinology and Metabolism in the Elderly. Boston, Blackewell Scientific, 1991, pp 35-57.
58. Ghigo E, Arvat E, Gianotti L, Grottoli S, Rizzi G, Ceda GP, Camanni F: Aging and GH-releasing peptides; in Bercu B,Walker R (eds): Growth Hormone Secretagogues.New York, Serono Symposia, 1996, pp 415-431.
59. Frohman LA, Jansson JO: Growth hormone-releasing hormone. Endocr Rev 1986;7:223-231.
60. Muller EE, Nisticò G: Neurotransmitter regulation of the anterior pituitary; in Muller EE, Nisticò G (eds): Brain Messengers and the Pituitary. San Diego, Academic Press, 1989, pp 404-537.
61. Tannembaum GS: Genesis of episodic growth hormone secretion. J Pediatr Endocrinol 1993;6:273-282.
62. Hartman ML, Veldhuis JD, Thorner MO: Normal control of growth hormone secretion. Horm Res 1993;40:37-47.
63. Bowers CY, Veeraragavan K, Sethumadhavan K: Atypical growth hormone-releasing peptides; in Bercu B, Walker R (eds): Growth Hormone. II. Basic and Clinical Aspects. New York, Springer, 1993, pp 205-222.
64. Micic D, Mallo F, Peino R, Cordido F, Leal-Cerro A, Garcia-Mayor RV, Casanueva FF: Regulation of growth hormone secretion by the growth hormone-releasing hexapeptide (GHRP-6). J Pediatr Endocrinol 1993;6:283-289.
65. Deghenghi R, Boutignon F, Luoni M, Grilli R, Guidi M, Locatelli V: Small peptides as potent releasers of growth hormone. J Pediatr Endocrinol Metab 1995;8:311-313.
66. Korbonits M, Grossman AB: Growth hormone-releasing peptide and its analogs. Novel stimuli to growth hormone release. Trends Endocrinol Metabol 1995;6:43-49.
67. DeVita RJ, Wyratt MJ: Benzolactam growth hormone secretagogues. Drugs Future 1996;21:273-281.
68. Ghigo E, Arvat E, Muccioli G, Camanni F: Growth hormone-releasing peptides. Eur J Endocrinol 1997;136:445-460.
69. Casanueva FF, Micic D, Pombo M, Leal A, Bokser L, Zugaza JL, Dieguez C: Role of the new growth hormone-releasing secretagogues in the diagnosis of some hypothalamo-pituitary pathologies. Metabolism 1996;45(suppl 1):123-126.
70. Howard AD, Feighner SD, CullyDF, Arena JP, Liberator PA, Rosenblum CI: A receptor in pituitary and hypothalamus that functions in growth hormone release. Science 1996;273:974-977.
71. Vrontakis ME, Torsello A, Friesen HG: Galanin. J Endocrinol Invest 1981;14:785-794.
72. Moncada S, Highs A: The L-arginine-nitric oxide pathway. N Engl J Med 1993;329:2002-2012.
73. Berelowitz M, Szabo M, Frohman LA, Firestone S, Chu L, Hintz RL: Somatomedin C effects on both the hypothalamus and the pituitary. Science 1981;212:1279-1288.
74. Ceda GP: IGFs in the feedback control of GH secretion: Hypothalamic and/or pituitary action? J Endocrinol Invest 1995;18:734-737.
75. Melmed S: Insulin suppresses growth hormone secretion by rat pituitary cells. J Clin Invest 1984;73:1425-1433.
76. Ghigo E, Bartolotta E, Imperiale E, Bellone J, Cardinale G, Aimaretti G, Valetto MR, Cherubini V, Maccario M, Cocchi D, Camanni F: Glucagon stimulates GH secretion after intramuscular but not intravenous administration. Evidence against the assumption that glucagon per se has a GH-releasing activity. J Endocrinol Invest 1994;17:849-854.
77. Dieguez C, Mallo F, Senaris R, Pineda J, Martul P, Leal-Cerro A, Pombo M, Casanueva FF: Role of glucocorticoids in the neuroregulation of growth hormone secretion. J Pediatr Endocrinol Metab 1996;9:255-260.
78. Wajchenberg BL, Liberman B, Giannella Neto D, Morozimato MY, Semer M, Bracco LO, Salgado LR, Knoepfelmacher M, Borges MH, Pinto AC, Kater CE, Lengyel AM: Growth hormone axis in Cushing's syndrome. Horm Res 1996;45:99-107.
79. Valcavi R, Zini M, Portioli I: Thyroid hormones and growth hormone secretion. J Endocrinol Invest 1992;14:313-330.
80. Giustina A, Wehrenberg WB: Influence of thyroid hormones on the regulation of growth hormone secretion. Eur J Endocrinol 1995;133:646-653.
81. Gaspard T, Wondergen R, Hamamdzic M, Klitgaard HM: Serum somatomedin stimulation in thyroxine-treated hypophysectomized rats. Endocrinology 1978;102:606-610.
82. Valcavi R: Oral glucose tolerance test: An inhibitory or a stimulatory input to growth hormone secretion? J Endocrinol Invest 1996;19:253-255.
83. Mercado M, Baumann G: Characteristics of the somatotropic axis in insulin-dependent diabetes mellitus. Arch Med Res 1995;26:101-109.
84. Melmed S: Acromegaly. Metabolism 1996;45(suppl 1):51-52.
85. Lamberts SW, de Herder W, Kwekkedom DJ, van der Lely AJ, Nobels FR, Krenning EP: Current tools in the diagnosis of pituitary tumours. Acta Endocrinol 1993;12:6-12.
86. Ezzat S, Forster MJ, Berchtold P, Rederlmeier DA, Boerling V, Harris AG: Acromegaly. Clinical and biochemical features in 500 patients. Medicine 1994;73:233-240.
87. Faglia G, Arosio M, Spada A: GS protein mutations and pituitary tumours: Functional correlates and possible therapeutic implications. Metabolism 1996;45:117-119.
88. Liuzzi A, Oppizzi G, Cozzi R, Dallabonzana D, Petroncini M, Orlandi P, Chiodini PG: GH regulation in acromegaly. J Pediatr Endocrinol 1993;6:339-343.
89. Zadik Z, Chalew SA, Kowarsky AA: The definition of a spontaneous growth hormone (GH) peak: Studies in normally growing and GH-deficient children. J Clin Endocrinol Metab 1992;74:801-805.
90. Camanni F, Ghigo E, Aimaretti G, Gianotti L, Bellone J, Imperiale E: Diagnosis of growth hormone deficiency; in Andreoli M, Shields M (eds): Highlights in Molecular and Clinical Endocrinology. Frontiers in Endocrinology. New York, Ares-Serono Symposia, 1994, vol 9, pp 211-217.
91. de Boer H, Block GJ, Poo-Synders C, van der Veen EA: Diagnosis of growth hormone deficiency in adults. Lancet 1994;343:1645-1646.
92. Ho KK, Hoffman DM: Defining growth hormone deficiency in adults. Metabolism 1995;44(suppl 4):91-96.
93. Laron Z, Buternandt O: Optimum use of growth hormone in children. Drugs 1991;42:1-8.
94. Casanueva FF: Diagnosis of growth hormone deficiency in adulthood. Eur J Endocrinol 1996;135:168-170.
95. Thorner MO, Bengtsson BA, Ho KY, Albertsson-Wikland K, Christiansen JS, Faglia G, Irie M, Isaksson O, Jorgensen JO, Ranke M: The diagnosis of growth hormone deficiency in adults. J Clin Endocrinol Metab 1995;80:3097-3098.
96. The Growth Hormone Research Society Group: Consensus guidelines for diagnosis and treatment of adults with GH deficiency. J Clin Endocrinol Metab 1998;83(2):382-395.
97. Giustina A, Romanelli G, Candrina R, Giustina G: Growth hormone deficiency in patients with idiopathic adrenocorticotrophin deficiency resolves during glucocorticoid replacement. J Clin Endocrinol Metab 1989;68:120-124.
98. Mehls O, Blum WF, Schaefer F, Tonshoff B, Scharer K: Growth failure in renal disease; in Bierich JR (ed): Growth Disorders. Clin Endocrinol Metab. London, Baillière Tindall, 1992, vol 6, pp 665-685.
99. Laron Z, Klinger B: Laron syndrome: Clinical features, molecular pathology and treatment. Horm Res 1994;42:198-202.
100. Rosenfeld RG, Rosenbloom AL, Guevara-Aguirre J: Growth hormone (GH) insensitivity due to primary GH receptor deficiency. Endocr Rev 1994;15:369-390.
101. Underwood LE, Backeljauw P: Therapy with recombinant human insulin-like growth factor I in children with insensitivity to growth hormone and in catabolic conditions. J Intern Med 1993;234:571-577.
102. Sassolas G: Potential therapeutic applications of GH in adults. Horm Res 1994;42:72-78.
103. Wilmore DW: Growth hormone and growth factors in catabolic illness. Endocrinol Metab 1995;2(suppl B):77-84.